Showing results (11-20 of 251) with videos related to
Sort By:
Pageof 26
British Journal of Cancer|July 5, 2001
Tcf-3 expression and beta-catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)S Tejpar, C Li, C Yu, et al.Acta Gastro-Enterologica Belgica|March 19, 2022
Prevalence of microsatellite instable and Epstein-Barr Virus-driven gastroesophageal cancer in a large Belgian cohortS De Meulder, X Sagaert, H Brems, et al.Gastrointestinal Endoscopy Clinics of North America|October 1, 1996
Pharmacologic therapy of arteriovenous malformationsE Van Cutsem, H PiessevauxAnnals of Oncology : Official Journal of the European Society for Medical Oncology|July 14, 2005
Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitorsS Segaert, E Van CutsemBulletin Du Cancer|February 5, 1999
[Irinotecan monotherapy in the treatment of colorectal cancers: results of phase II trials]E Van Cutsem, M PeetersColorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 11, 2013
The role of oxaliplatin in the management of upper gastrointestinal tract malignanciesW Scheithauer, E Van CutsemCurrent Opinion in Oncology|July 23, 1999
Developments in fluoropyrimidine therapy for gastrointestinal cancerE Van Cutsem, M PeetersJournal Belge De Radiologie|January 1, 1991
Epidemiology and clinical aspects of esophageal cancerE Van Cutsem, G VantrappenSeminars in Oncology|April 23, 1999
Irinotecan versus infusional 5-fluorouracil: a phase III study in metastatic colorectal cancer following failure on first-line 5-fluorouracil. V302 Study GroupE Van Cutsem, G H BlijhamAnnals of Oncology : Official Journal of the European Society for Medical Oncology|June 18, 2003
Current treatments and future perspectives in colorectal and gastric cancerH-J Wilke, E Van CutsemPageof 26